1. Home
  2. NRXP vs CLST Comparison

NRXP vs CLST Comparison

Compare NRXP & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • CLST
  • Stock Information
  • Founded
  • NRXP 2015
  • CLST 1922
  • Country
  • NRXP United States
  • CLST United States
  • Employees
  • NRXP N/A
  • CLST N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • CLST
  • Sector
  • NRXP Health Care
  • CLST
  • Exchange
  • NRXP Nasdaq
  • CLST Nasdaq
  • Market Cap
  • NRXP 51.3M
  • CLST 51.0M
  • IPO Year
  • NRXP N/A
  • CLST N/A
  • Fundamental
  • Price
  • NRXP $2.28
  • CLST $11.72
  • Analyst Decision
  • NRXP Strong Buy
  • CLST
  • Analyst Count
  • NRXP 3
  • CLST 0
  • Target Price
  • NRXP $31.67
  • CLST N/A
  • AVG Volume (30 Days)
  • NRXP 464.9K
  • CLST 4.3K
  • Earning Date
  • NRXP 03-27-2025
  • CLST 01-23-2025
  • Dividend Yield
  • NRXP N/A
  • CLST N/A
  • EPS Growth
  • NRXP N/A
  • CLST N/A
  • EPS
  • NRXP N/A
  • CLST N/A
  • Revenue
  • NRXP N/A
  • CLST $5,174,000.00
  • Revenue This Year
  • NRXP N/A
  • CLST N/A
  • Revenue Next Year
  • NRXP N/A
  • CLST N/A
  • P/E Ratio
  • NRXP N/A
  • CLST N/A
  • Revenue Growth
  • NRXP N/A
  • CLST N/A
  • 52 Week Low
  • NRXP $1.10
  • CLST $10.78
  • 52 Week High
  • NRXP $7.33
  • CLST $12.10
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 38.85
  • CLST 51.74
  • Support Level
  • NRXP $2.80
  • CLST $11.68
  • Resistance Level
  • NRXP $3.07
  • CLST $11.75
  • Average True Range (ATR)
  • NRXP 0.29
  • CLST 0.05
  • MACD
  • NRXP -0.10
  • CLST 0.00
  • Stochastic Oscillator
  • NRXP 2.52
  • CLST 75.00

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a federally chartered community-oriented savings bank. The bank is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources which are used for the origination of loans. The Bank derives its income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.

Share on Social Networks: